Po and Pb in forest mushrooms of genus Leccinum and topsoil from northern Poland and its contribution to the radiation dose.

Chemosphere

Laboratory of Environmental Analytics and Radiochemistry, Environmental Chemistry and Radiochemistry Department, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland. Electronic address:

Published: December 2018

Wild growing mushrooms are traditional food items for man and also an important source of nutrients for small and big wildlife. Nevertheless, they can be species - specifically vulnerable for contamination with heavy metals and radionuclides. We studied a less known phenomenon of accumulation of highly toxic, the alpha-radiation emitter such as Po and the beta emitter Pb by three Leccinum mushrooms: orange oak bolete L. aurantiacum (Bull.) Gray (previous name Leccinum aurantiacum var. quercinum Pilát), foxy bolete L. vulpinum Watling and slate bolete L. duriusculum (Schulzer ex Kalchbr.) Singer. Fungal and soil materials were collected from areas of a different geochemical composition in the northern regions of Poland. In parallel evaluated was the risk to human consumer due to possible intake of Po and Pb with a mushroom meal. Results showed a heterogeneous distribution of Po and Pb activity concentrations within caps and stipes of fruiting bodies. Overall activity concentration for whole dried fungi material ranged from 0.59 ± 0.38 to 3.2 ± 0.2 Bq Po kg and from 0.45 ± 0.04 to 3.1 ± 0.2 Bq Pb kg. Evaluation showed that Leccinum mushrooms consumed by locals in typical quantity of 0.5 kg (dry biomass) can contribute into annual effective radiation dose at 0.90-3.81 μSv from Po decay and 0.31-2.14 μSv from Pb decay, which is a small portion of the annual effective radiation dose of Po and Pb for human inhabiting the northern regions of Poland.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chemosphere.2018.09.022DOI Listing

Publication Analysis

Top Keywords

radiation dose
12
leccinum mushrooms
8
northern regions
8
regions poland
8
annual effective
8
effective radiation
8
forest mushrooms
4
mushrooms genus
4
leccinum
4
genus leccinum
4

Similar Publications

Betel nut chewing, common in several Asian populations, is linked to increased cancer risk, including oral, esophageal, gastric, and hepatocellular carcinoma. Aspirin shows potential as a chemopreventive agent. This study investigates the association between aspirin use and cancer risk among betel nut chewers.

View Article and Find Full Text PDF

Radiation therapy is one of the most effective treatments for approximately 60% of patients with cancer. During radiation exposure, the overproduction of reactive oxygen species (ROS) disrupts the lipid layer of the membrane, leading to subsequent peroxide radical formation. Cimetidine (Cim) and famotidine (Fam) are histamine H2 receptor antagonists (H2 blocker), also known as peptic ulcer drugs, that exert radioprotective effects.

View Article and Find Full Text PDF

Background And Purpose: Radiotherapy for paediatric posterior fossa tumours may cause complications in the brainstem and upper spinal cord due to high doses. With proton therapy (PT) this risk may increase due to higher relative biological effectiveness (RBE) from elevated linear energy transfer (LET). This study assesses variations in LET in the brainstem and spinal cord in proton treatment plans from European centres.

View Article and Find Full Text PDF

Objectives: Head and neck malignancies (HNMs) encompass a variety of cancers that affect the oral and para-oral tissues, the most common of which are squamous cell carcinomas. Radiotherapy is commonly used to treat these cancers, often involving radiation exposure to the salivary glands. This study aims to investigate the early impacts of radiotherapy on the internal microstructure of the salivary gland cells and identify which gland exhibits the highest level of radiosensitivity.

View Article and Find Full Text PDF

Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint Inhibitors.

Gastroenterology Res

December 2024

Division of Medical Oncology, Department of Internal Medicine, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

Background: Immune checkpoint inhibitors (ICIs) have moved to the frontline in recent years to manage upper gastrointestinal (UGI) tumors, such as esophageal and gastric cancers. This retrospective review sheds light on real-world data on ICI-treated UGI tumors to identify risk factors (clinical and pathological) impacting the outcome other than traditional biomarkers (programmed cell death ligand 1 (PD-L1) or microsatellite instability status).

Methods: Patients with UGI tumors who received at least one dose of ICI for stage IV or recurrent disease between January 1, 2015, and July 31, 2021, at The Ohio State University were included in the study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!